|
1
|
Benign breast disease and the risk of breast cancer.
|
N Engl J Med
|
2005
|
6.84
|
|
2
|
Genetic variation and cancer: improving the environment for publication of association studies.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
6.24
|
|
3
|
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
|
Nat Genet
|
2009
|
6.04
|
|
4
|
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
|
Nat Genet
|
2013
|
5.58
|
|
5
|
Age-related lobular involution and risk of breast cancer.
|
J Natl Cancer Inst
|
2006
|
5.12
|
|
6
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
|
Nat Genet
|
2013
|
4.35
|
|
7
|
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
Nat Genet
|
2010
|
3.86
|
|
8
|
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
Nat Genet
|
2013
|
3.42
|
|
9
|
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies.
|
Ann Intern Med
|
2004
|
3.18
|
|
10
|
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
Nat Genet
|
2011
|
3.07
|
|
11
|
Mammographic breast density as a general marker of breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
2.81
|
|
12
|
Mammographic density, breast cancer risk and risk prediction.
|
Breast Cancer Res
|
2007
|
2.71
|
|
13
|
Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
|
J Clin Oncol
|
2007
|
2.58
|
|
14
|
Transforming epidemiology for 21st century medicine and public health.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.56
|
|
15
|
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
|
Am J Gastroenterol
|
2006
|
2.38
|
|
16
|
Epidemiology of ovarian cancer.
|
Methods Mol Biol
|
2009
|
2.18
|
|
17
|
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
|
Clin Cancer Res
|
2011
|
2.09
|
|
18
|
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
|
J Clin Oncol
|
2005
|
2.09
|
|
19
|
Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study.
|
Am J Epidemiol
|
2008
|
2.06
|
|
20
|
Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies.
|
Am J Clin Nutr
|
2005
|
1.97
|
|
21
|
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
|
Cancer Res
|
2007
|
1.92
|
|
22
|
Longitudinal trends in mammographic percent density and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.90
|
|
23
|
Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.81
|
|
24
|
Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
|
Arch Intern Med
|
2006
|
1.77
|
|
25
|
Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
|
Am J Epidemiol
|
2002
|
1.76
|
|
26
|
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.75
|
|
27
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Nat Commun
|
2013
|
1.73
|
|
28
|
Association between mammographic density and age-related lobular involution of the breast.
|
J Clin Oncol
|
2010
|
1.70
|
|
29
|
Texture features from mammographic images and risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.65
|
|
30
|
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
|
Cancer Res
|
2011
|
1.64
|
|
31
|
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
|
Genes Chromosomes Cancer
|
2004
|
1.64
|
|
32
|
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
|
Cancer Res
|
2009
|
1.59
|
|
33
|
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
|
J Natl Cancer Inst
|
2012
|
1.48
|
|
34
|
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
|
Hum Mol Genet
|
2012
|
1.47
|
|
35
|
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
|
PLoS Genet
|
2010
|
1.47
|
|
36
|
Proteomic contributions to personalized cancer care.
|
Mol Cell Proteomics
|
2008
|
1.46
|
|
37
|
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.45
|
|
38
|
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
|
Cancer Res
|
2008
|
1.42
|
|
39
|
Epidemiology - identifying the causes and preventability of cancer?
|
Nat Rev Cancer
|
2006
|
1.38
|
|
40
|
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
|
Nat Commun
|
2013
|
1.36
|
|
41
|
An automated approach for estimation of breast density.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.35
|
|
42
|
Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study.
|
Cancer
|
2002
|
1.35
|
|
43
|
Examining population stratification via individual ancestry estimates versus self-reported race.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.33
|
|
44
|
Performance of amplified DNA in an Illumina GoldenGate BeadArray assay.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.32
|
|
45
|
Inherited determinants of ovarian cancer survival.
|
Clin Cancer Res
|
2010
|
1.32
|
|
46
|
Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
|
Clin Gastroenterol Hepatol
|
2006
|
1.31
|
|
47
|
No association between 25-hydroxyvitamin D and mammographic density.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.31
|
|
48
|
A novel automated mammographic density measure and breast cancer risk.
|
J Natl Cancer Inst
|
2012
|
1.28
|
|
49
|
Case-control study of increased mammographic breast density response to hormone replacement therapy.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.28
|
|
50
|
Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.28
|
|
51
|
Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies.
|
Int J Cancer
|
2006
|
1.26
|
|
52
|
Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
|
Cancer Res
|
2007
|
1.26
|
|
53
|
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
|
Breast Cancer Res Treat
|
2006
|
1.25
|
|
54
|
Retracted
MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
|
J Biol Chem
|
2012
|
1.22
|
|
55
|
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
|
Ann Surg Oncol
|
2010
|
1.21
|
|
56
|
Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.19
|
|
57
|
Comparison of percent density from raw and processed full-field digital mammography data.
|
Breast Cancer Res
|
2013
|
1.19
|
|
58
|
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
|
Cancer Res
|
2002
|
1.17
|
|
59
|
Can genes for mammographic density inform cancer aetiology?
|
Nat Rev Cancer
|
2008
|
1.17
|
|
60
|
Integrative cancer epidemiology--the next generation.
|
Cancer Discov
|
2012
|
1.16
|
|
61
|
Preventive health behaviors and familial breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.15
|
|
62
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.14
|
|
63
|
Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer.
|
Mayo Clin Proc
|
2005
|
1.12
|
|
64
|
Breast biopsy utilization: a population-based study.
|
Arch Intern Med
|
2005
|
1.12
|
|
65
|
The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
|
Breast Cancer Res
|
2012
|
1.11
|
|
66
|
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
|
Cancer
|
2003
|
1.11
|
|
67
|
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.11
|
|
68
|
Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.09
|
|
69
|
Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.
|
Clin Cancer Res
|
2008
|
1.09
|
|
70
|
The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history.
|
J Gen Intern Med
|
2005
|
1.09
|
|
71
|
Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.
|
J Urol
|
2006
|
1.09
|
|
72
|
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
|
J Natl Cancer Inst
|
2012
|
1.04
|
|
73
|
Relative weight at age 12 and risk of postmenopausal breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.03
|
|
74
|
Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women.
|
Cancer Causes Control
|
2004
|
1.01
|
|
75
|
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.01
|
|
76
|
Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.00
|
|
77
|
Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women.
|
Clin Gastroenterol Hepatol
|
2003
|
0.99
|
|
78
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Hum Genet
|
2013
|
0.99
|
|
79
|
Body size and incident colorectal cancer: a prospective study of older women.
|
Cancer Prev Res (Phila)
|
2010
|
0.98
|
|
80
|
Prenatal and perinatal correlates of adult mammographic breast density.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.98
|
|
81
|
Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states.
|
Am J Epidemiol
|
2007
|
0.98
|
|
82
|
Ovarian cancer risk associated with inherited inflammation-related variants.
|
Cancer Res
|
2012
|
0.98
|
|
83
|
Reoperations after prophylactic mastectomy with or without implant reconstruction.
|
Cancer
|
2003
|
0.96
|
|
84
|
A comprehensive examination of CYP19 variation and breast density.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.96
|
|
85
|
A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.
|
Cancer
|
2008
|
0.96
|
|
86
|
Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
|
Urology
|
2007
|
0.95
|
|
87
|
Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.
|
Epidemiology
|
2002
|
0.94
|
|
88
|
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.94
|
|
89
|
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
|
BMC Cancer
|
2009
|
0.93
|
|
90
|
Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
|
PLoS One
|
2013
|
0.93
|
|
91
|
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.92
|
|
92
|
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.92
|
|
93
|
MTHFR polymorphisms in relation to ovarian cancer risk.
|
Gynecol Oncol
|
2010
|
0.90
|
|
94
|
Risk of ovarian cancer and inherited variants in relapse-associated genes.
|
PLoS One
|
2010
|
0.90
|
|
95
|
Alcohol intake in adolescence and mammographic density.
|
Int J Cancer
|
2005
|
0.90
|
|
96
|
Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.
|
BMC Med Genet
|
2011
|
0.90
|
|
97
|
Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.
|
Methods Mol Biol
|
2009
|
0.90
|
|
98
|
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
|
Cancer Res
|
2013
|
0.89
|
|
99
|
Factors associated with breast cancer prevention communication between mothers and daughters.
|
J Womens Health (Larchmt)
|
2008
|
0.88
|
|
100
|
Identification of a novel percent mammographic density locus at 12q24.
|
Hum Mol Genet
|
2012
|
0.88
|
|
101
|
Germline copy number variation and ovarian cancer survival.
|
Front Genet
|
2012
|
0.88
|
|
102
|
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
|
Twin Res Hum Genet
|
2010
|
0.87
|
|
103
|
Familial and perceived risk of breast cancer in relation to use of complementary medicine.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.87
|
|
104
|
Fostering transdisciplinary science.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.86
|
|
105
|
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.
|
BMC Med Genomics
|
2014
|
0.86
|
|
106
|
A latent model for prioritization of SNPs for functional studies.
|
PLoS One
|
2011
|
0.86
|
|
107
|
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
|
Mol Carcinog
|
2010
|
0.86
|
|
108
|
Gene variants in the angiogenesis pathway and prostate cancer.
|
Carcinogenesis
|
2012
|
0.85
|
|
109
|
Bilateral oophorectomy and breast cancer risk reduction among women with a family history.
|
Cancer Detect Prev
|
2004
|
0.85
|
|
110
|
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.85
|
|
111
|
Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.
|
Genet Test Mol Biomarkers
|
2014
|
0.85
|
|
112
|
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
|
113
|
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.84
|
|
114
|
The beginning of the end for the epidemiologic focus on gene-environment interactions?
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.83
|
|
115
|
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.82
|
|
116
|
Dietary patterns and breast density in the Minnesota Breast Cancer Family Study.
|
Cancer Causes Control
|
2008
|
0.82
|
|
117
|
Mammographic density of the breast.
|
N Engl J Med
|
2003
|
0.82
|
|
118
|
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
|
Cancer Immunol Res
|
2014
|
0.82
|
|
119
|
Evaluation of a training program to prepare community health representatives to promote breast and cervix cancer screening among native american women.
|
J Cancer Educ
|
2004
|
0.81
|
|
120
|
Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA).
|
Cancer Causes Control
|
2004
|
0.81
|
|
121
|
Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study.
|
Nutr Cancer
|
2008
|
0.81
|
|
122
|
Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.81
|
|
123
|
IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.81
|
|
124
|
Common variation in Nemo-like kinase is associated with risk of ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.80
|
|
125
|
Outcomes of training nurses to conduct breast and cervical cancer screening of Native American women.
|
Holist Nurs Pract
|
2002
|
0.78
|
|
126
|
Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.
|
Urology
|
2011
|
0.78
|
|
127
|
Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study.
|
Psychooncology
|
2009
|
0.78
|
|
128
|
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
|
PLoS One
|
2011
|
0.78
|
|
129
|
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.
|
Anticancer Res
|
2012
|
0.77
|
|
130
|
Retracted
Risk factors for ovarian cancers with and without microsatellite instability.
|
Int J Gynecol Cancer
|
2013
|
0.77
|
|
131
|
Risk factors for ovarian cancers with and without microsatellite instability.
|
Int J Gynecol Cancer
|
2014
|
0.77
|
|
132
|
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
|
Mol Nutr Food Res
|
2014
|
0.77
|
|
133
|
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
|
Oncol Rep
|
2013
|
0.76
|
|
134
|
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.
|
Front Genet
|
2012
|
0.76
|
|
135
|
Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women's Health Study.
|
Int J Cancer
|
2008
|
0.76
|
|
136
|
European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry.
|
PLoS One
|
2012
|
0.76
|
|
137
|
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
|
Am J Epidemiol
|
2016
|
0.75
|
|
138
|
No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density.
|
Breast Cancer Res
|
2012
|
0.75
|
|
139
|
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
|
Cancer Epidemiol Biomarkers Prev
|
2016
|
0.75
|
|
140
|
Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population.
|
BMC Med Genet
|
2010
|
0.75
|
|
141
|
Null results in brief: meeting a need in changing times.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.75
|
|
142
|
Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.75
|
|
143
|
Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study.
|
Cancer Detect Prev
|
2003
|
0.75
|
|
144
|
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
|
J Biol Chem
|
2016
|
0.75
|
|
145
|
Genetic ancestry and molecular epidemiology.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.75
|
|
146
|
Improving completeness and quality of epidemiologic study publications.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.75
|
|
147
|
Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal.
|
Cancer Prev Res (Phila)
|
2008
|
0.75
|
|
148
|
Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β. LncRNA-HIT-MEDIATED TGF-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA.
|
J Biol Chem
|
2016
|
0.75
|